Delphine Charvin is CEO and co-founder of Elkedonia. A neuroscientist by training, she has held several CSO positions in start-ups, scale-ups, and pharma companies. She co-founded Prexton Therapeutics, later acquired by Lundbeck in a landmark $1 billion deal. Before founding Elkedonia, she was Operating Partner at Argobio, a start-up studio, where she identified the innovative project that became Argobio’s first spin-out. Under her leadership, Elkedonia successfully raised €11+ million in May this year.